The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction
NCT ID: NCT00609908
Last Updated: 2015-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
30 participants
INTERVENTIONAL
2007-12-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A randomized controlled trial is performed to evaluate the clinical effectiveness of the skin stretching technique for two categories:
1. acute burn wounds: wound closure by means of skin stretching should lead to a significant reduction of scar surface area in comparison to the standard technique, the split skin grafting;
2. scar reconstructions: wound closure by means of skin stretching during one operative procedure should lead to a comparable scar surface in comparison to the multiple procedures techniques such as serial excision.
Study design:
Skin stretching will be compared to split skin grafting and should result in burn wound closure with significantly smaller scars. Also, a comparison will be made between the technique of serial excision versus skin stretching for scar reconstructions.
Scar evaluation three and twelve months after surgery will include the following parameters:
* surface area;
* Patient and Observer Scar Assessment Scale (POSAS);
* elasticity;
* vascularization and pigmentation;
* thickness;
* dermal architecture.
After 12 months adults will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the skin stretcher will undergo one extra biopsy of the formerly stretched skin.
Intervention:
At the start of the operation will be determined by randomization if skin stretching or split skin grafting (acute burn wounds) or serial excision (scar reconstruction category) will be performed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of Cultured Autologous Keratinocytes for Burn Wound Healing
NCT00832156
Perforator Based Interposition Plasty
NCT01409759
Dermal Substitute and Topical Negative Pressure in Burns
NCT00548314
Aquatic Training in Patients With Severe Scarring
NCT01433198
Biological Skin Graft With Keratinocyte-stem Cell Co-cultre for Burn Patients
NCT05652816
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inclusion:
1\. Acute Burn wounds or scar reconstructions that require surgical treatment; 2. Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure.
3\. Age \>= 18 years
Exclusion:
1. language barrier;
2. known history of keloid formation;
3. systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
4. local or systemic application of corticosteroids;
5. psychiatric diseases leading to study bias (e.g. automutilation);
6. skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
7. radiated skin;
8. wound located at extremities, exceeding \>33% of circumference (acute burn category);
Primary study parameters/outcome of the study:
The primary study parameter is the surface area of the scar after 12 months
Secondary study parameters/outcome of the study (if applicable):
All scars will also be subjected to the scar evaluation protocol after 3 and 12 months by an independent observer for the evaluation of the:
* patient and observer scar assessment scale (POSAS);
* scar elasticity (Cutometer);
* scar vascularisation \& pigmentation (DermaSpectrometer);
* scar thickness (histopathology, only after 12 months).
Punch biopsies are taken for morphometry of dermal architecture (Fourier analysis). During surgery one biopsy is obtained of the normal skin. In the experimental group an additional biopsy is obtained at the end of the stretching procedure in order to be able to compare structure of the dermal matrix and orientation of the collagen fibers.
After 1 year, one biopsy is taken from the scar. The experimental group will undergo one additional biopsy of the formerly stretched skin.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A1
Acute Burn Wounds: Wound debridement and split skin grafting
Split skin graft
After wound bed preparation the skin defect is covered with a skin transplant (split skin graft)
A2
Acute Burn Wounds: excision of the burn wound and primary closure, using a skin stretching device
skin stretching device
after woundbed preparation the wound is primarily closed by aid of the skin stretching device
B1
Scar reconstruction: serial excision
serial excision
as much scar as possible is excised, whereafter the wound is closed
B2
Scar reconstruction: primary closure, using skin stretching device
skin stretching device
after the scar is excised, the wound is primarily closed by aid of the skin stretching device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Split skin graft
After wound bed preparation the skin defect is covered with a skin transplant (split skin graft)
skin stretching device
after woundbed preparation the wound is primarily closed by aid of the skin stretching device
serial excision
as much scar as possible is excised, whereafter the wound is closed
skin stretching device
after the scar is excised, the wound is primarily closed by aid of the skin stretching device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure;
* Age \>= 18 years.
Exclusion Criteria
* Known history of keloid formation;
* Systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
* Local or systemic application of corticosteroids;
* Psychiatric diseases leading to study bias (e.g. automutilation);
* Skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
* Radiated skin;
* Wound located at extremities, exceeding \>33% of circumference (acute burn category).
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association of Dutch Burn Centres
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Association of Dutch Burn Centres
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
E Middelkoop, Professor
Role: PRINCIPAL_INVESTIGATOR
VU MC
P.P.M. van Zuijlen, MD, PhD
Role: STUDY_DIRECTOR
Red Cross Hospital Beverwijk
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Red Cross Hospital
Beverwijk, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06.201
Identifier Type: -
Identifier Source: secondary_id
06.201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.